It takes a team to remove large, aggressive tumors
July 26, 2011 in Cancer(Medical Xpress) -- No cancer surgery is easy, but the two operations David Bieszke underwent at Loyola University Hospital to remove an aggressive, 10-inch tumor were especially challenging.
The tumor extended from his navel to his diaphragm. It choked a major blood vessel and invaded smaller blood vessels to both kidneys.
It would take two surgeries, each lasting 6 hours, to remove the tumor. There was a significant risk that Mr. Bieszke could lose one or both kidneys. He might have to go on a heart-lung bypass machine during surgery. There was even a chance he could bleed to death.
"I was really scared," said Mr. Bieszke, 47, who lives in Geneva, Ill.
Three days before the first surgery, David and Jennifer Bieszke got married. They had been together for 18 years, and David had asked Jennifer more than once to get married. As he faced the difficult and risky surgery, she finally said yes.
"I realized that if I lost him, I would always regret that we hadn't gotten married," Jennifer Bieszke said. "That piece of paper had become very important to me."
The two-part operation was a multidisciplinary effort that required exhaustive planning and close teamwork among four top surgeons, an anesthesiologist, the head nurse and the rest of the operating team.
"Everyone worked together so well," said surgical oncologist Dr. Margo Shoup, who coordinated the team. "It was like a beautiful sympathy."
The team was able to remove the entire tumor and save one of Mr. Bieszke's kidneys. Four weeks after his second surgery, Mr. Bieszke returned to work as an auto mechanic. He feels better now than he has in a long time.
Prior to surgery, Mr. Bieszke suffered pain near his stomach for more than a year. He took ibuprofen three or four times a day, lost his appetite and suffered extreme fatigue.
He finally was diagnosed on April 3. An oncologist at a community hospital referred Mr. Bieszke to Dr. Shoup, because it would require an academic medical center such as Loyola to perform the highly specialized, multidisciplinary surgery.
The cancer, relatively rare, is known as vena cava sarcoma. Doctors believe it originated in the vena cava, the largest vein in the body. By the time Mr. Bieszke was diagnosed, the tumor had completely blocked the vena cava, forcing the body to grow alternative blood vessels.
The first surgery was performed April 29. Surgeons successfully removed the left side of the tumor, but were unable to save the left kidney.
The second surgery was performed June 13. Dr. Shoup worked closely with vascular surgeon Dr. Ross Milner, kidney transplant surgeon Dr. Amy Lu, cardiothoracic surgeon Dr. Robert Love, anesthesiologist Dr. Jeffrey Hartwig and head nurse Jill Anderson.
Dr. Lu and Dr. Milner removed cancerous parts of blood vessels to the right kidney and then reconstructed the blood vessels. There was a chance Dr. Lu would have to remove the kidney and, in effect, transplant it back in a different location. Fortunately, that wasn't necessary. Mr. Bieszke's right kidney stayed in place and is working normally.
Dr. Love was available in the event the tumor reached the heart and Mr. Bieszke would have to be put on a heart-lung bypass machine during the surgery. Perfusionists also were set up and ready to go on bypass at any time. Fortunately, this wasn't necessary, either.
Dr. Milner removed about 5 inches of the vena cava and Dr. Shoup removed the rest of the tumor. Dr. Hartwig infused blood to make up for blood loss and kept Mr. Biezke's vital signs stable throughout the surgery. Ms. Anderson was instrumental in making the surgery proceed without a hitch.
Today, Mr. Bieszke appears to be cancer free. But he will need regular CT scans because there's a chance the cancer could come back.
He and his wife are confident it won't.
"And even if it does, we will have Dr. Shoup," Mrs. Biezke said. "We couldn't ask for more than that."
Provided by
Loyola University Health System
-
New laser for neurosurgery allows greater precision and efficiency for removal of complex tumors
Jan 28, 2009 |
not rated yet |
0
-
Teenager to have giant tumor removed
Apr 24, 2008 |
not rated yet |
0
-
Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
Aug 23, 2007 |
not rated yet |
0
-
Performing surgery on a beating heart may be safer
Jan 31, 2007 |
not rated yet |
0
-
MR arthrography is more accurate than MR in diagnosing shoulder tears
Jan 06, 2009 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
8 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
2 hours ago |
not rated yet |
0
|
Pancreatectomy OK without downstaging from therapy
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...
Cancer
3 hours ago |
not rated yet |
0
Common therapies for basal cell carcinoma offer similar survival
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...
Cancer
3 hours ago |
not rated yet |
0
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Cancer
5 hours ago |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
Cancer
8 hours ago |
not rated yet |
1
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
Implantable pain disk may help those with cancer
An estimated 3.5 million cancer patients around the globe are in severe pain from their disease, but many get no relief.
First study to suggest that the immune system may protect against Alzheimer's changes in humans
Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.
Physicians definitively links irritable bowel syndrome and bacteria in gut
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold ...